The Amsterdam UMC team, shown here, performed the VT ablation procedure following previous experiences performing atrial flutter and premature ventricular complex (PVC) ablation procedures guided by ...
Baltimore, MD - A report published this week has shown a high rate of ventricular tachycardia (VT) recurrence—as high as 75% at 14 months—in arrhythmogenic right ventricular dysplasia/cardiomyopathy ...
In a "strong statements and controversies" session at the European Heart Rhythm Association (EHRA) EUROPACE-CARDIOSTIM 2017 meeting, Prof Gerhard Hindricks (University of Leipzig, Germany) said ...
BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...
Please provide your email address to receive an email when new articles are posted on . High-risk patients getting catheter ablation for ventricular tachycardia did not benefit from a mechanical ...
Catheter ablation guided by electroanatomic mapping is now a viable treatment option to reduce episodes of recurrent ventricular tachycardia (VT) in patients who have experienced myocardial infarction ...
NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...
(MENAFN- AETOSWire) (BUSINESS WIRE )-- Imricor Medical Systems, Inc. ( Company or Imricor) ( ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam UMC), is pleased to announce the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback